ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ADAG Adagene Inc

2.26
0.00 (0.00%)
Pre Market
Last Updated: 11:52:21
Delayed by 15 minutes
Name Symbol Market Type
Adagene Inc NASDAQ:ADAG NASDAQ Depository Receipt
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  0.00 0.00% 2.26 2.26 2.80 0 11:52:21

Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]

07/11/2024 9:00pm

Edgar (US Regulatory)


 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 6-K/A

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16
OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the Month of November 2024

 

Commission File Number: 001-39997

 

 

 

Adagene Inc.

 

 

 

4F, Building C14, No. 218

Xinghu Street, Suzhou Industrial Park

Suzhou, Jiangsu Province, 215123

People’s Republic of China

+86-512-8777-3632

(Address of principal executive offices)

 

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F x   Form 40-F o

 

 

 

 

 

 

EXPLANATORY NOTE AND INCORPORATION BY REFERENCE

 

Adagene Inc. (the “Company”) is amending its report on Form 6-K furnished to the Securities and Exchange Commission on July 25, 2024 (File/Film Number: 001-39997/241142065) (the “Original 6-K”) in order to re-file and replace the Original 6-K. This Form 6-K/A is being furnished solely to correct a typographical error in the signature page to the Original 6-K. All other information included in the Original 6-K remains unchanged.

 

This report on Form 6-K/A shall be deemed to be incorporated by reference into the registration statements on Form F-3 (File No. 333-264486) and Form S-8 (File No. 333-255250) of the Company (including any prospectuses forming a part of such registration statements), and shall be a part thereof from the date on which this current report is furnished, to the extent not superseded by documents or reports subsequently filed or furnished.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Adagene Inc.
     
  By: /s/ Peter Luo
  Name: Peter Luo
  Title: Chief Executive Officer
     
Date: November 7, 2024    

 

 

 

 

EXHIBIT INDEX

 

Exhibit   Description
99.1   Press release tilted “Adagene Reports Six Month Financial Results for 2024 and Provides Corporate Update” (incorporated by reference to Exhibit 99.1 from the current report on Form 6-K (File/Film Number: 001-39997/241142065) on July 25, 2024))
99.2   Unaudited Interim Condensed Consolidated Financial Statements for the six months ended June 30, 2023 and 2024 (incorporated by reference to Exhibit 99.2 from the current report on Form 6-K (File/Film Number: 001-39997/241142065) on July 25, 2024))
101.INS   Inline XBRL Instance Document – this instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH   Inline XBRL Taxonomy Extension Schema
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase
104   Cover Page Interactive Data File (embedded within the Inline IXBRL document)

 

 

 

 


1 Year Adagene Chart

1 Year Adagene Chart

1 Month Adagene Chart

1 Month Adagene Chart

Your Recent History

Delayed Upgrade Clock